21st Century Medicine: Now It’s Personal

Thanks to breakthroughs in genome sequencing, personalized medicine is rapidly becoming more science than fiction. As experimental therapies are replaced with data-driven solutions, we may be closer than ever to the kind of patient-specific care that promises to revolutionize the way medicine is practiced.

In the Pipeline: Novel Plasma Proteins for Major Cardiovascular Disorders

OVER THE 70 years since biochemist Edwin Cohn and his Harvard Medical School laboratory first purified human albumin for use in severe burns and hemorrhagic trauma, nearly 30 therapeutic proteins from human plasma have been purified, proven safe and effective and approved for use. Most of these products (Table 1) are indicated as replacement therapies […]

Tuberculosis Vaccine Effective as Treatment for MS

A recent study shows that a vaccine typically used to prevent tuberculosis in countries outside of the U.S. could also prevent multiple sclerosis (MS) in people who are in the beginning stages of the disease.

New Gene May Be an Effective Target for Autoimmune Disease Therapy

Researchers at King’s College London have identified a new gene, PIM1, which could be an effective target for innovative treatments and therapies for psoriasis, an autoimmune disease.

Immune System Therapy Shows Promise in Adults with Leukemia

A recent study of an experimental therapy that alters cancer patients’ own immune cells to recognize an often deadly form of leukemia has shrunk tumors and sent the cancer into remission in adults.

Immune Globulin: Each Product Is Unique

While all IG products are comparably effective, they also have relevant differences that determine their tolerability by patients.

A Review of Coagulation Factor Disorders

Until better treatments or a cure can be found, coagulation factor replacement therapies continue to improve the long-term outcome for people with bleeding disorders

Breaking the Cancer Code

Scientific breakthroughs using gene therapy are allowing physicians to take a “precision medicine” approach to treating cancer — with promising results.

Superbugs: Reducing the Serious Threat of Hospital-Acquired Infections

Hospital-acquired infections remain a deadly threat, but the Centers for Disease Control and Prevention in partnership with other healthcare agencies and professionals are working to lower the rates of HAIs with some degree of success.

Hydroxyethyl Starch in Critically Ill Patients: The Verdict Is In

For resuscitation of patients with sepsis, the verdict is in: Hydroxyethyl starch products increase the risk of acute kidney injury and death.